Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second-generation, ...
Ultima Genomics today announced Francisco De La Vega, DSc, has joined the Company as Vice President, Germline Genomics & Distinguished Scientific Fellow. With over 25 years of leadership experience in ...
An established international forum draws ~850 participants from 60+ countries and broad sponsor/exhibitor support, enabling ...
Liquid handling solutions support NGS workflows by enhancing throughput, minimizing manual error and standardizing library ...
Inside the human gut lives a hidden world of trillions of microbes – and Professor Sam Forster is exploring how they shape ...
Key Takeaways - A recent white paper from PJM seeks to reframe the region’s resource adequacy debate around risk ...
Ellis Bio today announced that an independent evaluation by Roche, published in a new Tech Spotlight, found that the ...
EpiCypher® and New England Biolabs® (NEB®) today announced an expanded strategic partnership to co-develop next-generation ...
The Caris Lookback Program identified 13,293 patients potentially eligible for newly approved targeted therapies across 10 ...
Foundation Medicine, Inc., a global, patient-focused precision medicine company , today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne ® CDx ...
Clearmind Medicine Inc. (Nasdaq: CMND) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results